Edmunds; Jeremy John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Edmunds; Jeremy John.The latest application filed is for "inhibitors of factor xa and other serine proteases involved in the coagulation cascade".

Company Profile

0.7.14

Edmunds; Jeremy John - Ypsilanti MI
Edmunds; Jeremy John - Acton MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitors Of Factor Xa And Other Serine Proteases Involved In The Coagulation Cascade App 20090221546 - Bigge; Christopher Franklin ; et al.	2009-09-03
Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation Cascade App 20080287674 - Bigge; Christopher Franklin ; et al.	2008-11-20
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade Grant 7,407,972 - Edmunds August 5, 2	2008-08-05
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade Grant 7,407,974 - Bigge , et al. August 5, 2	2008-08-05
FACTOR Xa INHIBITOR App 20080171773 - Edmunds; Jeremy John ; et al.	2008-07-17
INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE App 20060264626 - Casimiro-Garcia; Agustin ; et al.	2006-11-23
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade Grant 7,030,141 - Bigge , et al. April 18, 2	2006-04-18
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade App 20050267118 - Edmunds, Jeremy John	2005-12-01
Inhibitors of fractor Xa and other serine proteases involved in the coagulation cascade App 20050250815 - Bigge, Christopher Franklin ; et al.	2005-11-10
Quinoxalinones as serine protease inhibitors Grant 6,916,805 - Dudley , et al. July 12, 2	2005-07-12
Quinolones as serine protease inhibitors Grant 6,855,726 - Dudley , et al. February 15, 2	2005-02-15
Piperazine derivative renin inhibitors App 20040214832 - Cai, Cuiman ; et al.	2004-10-28
Piperidine derivative rennin inhibitors App 20040204455 - Cody, Wayne Livingston ; et al.	2004-10-14
Benoxazinones/benzothiazinones as serine protease inhibitors App 20030187256 - Berryman, Kent Alan ; et al.	2003-10-02
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade App 20030162787 - Bigge, Christopher Franklin ; et al.	2003-08-28
Certain benzothiazine dioxide endothelin antagonists and processes for their preparation App 20030073684 - Bunker, Amy Mae ; et al.	2003-04-17
Certain benzothiazine dioxide endothelin antagonists and processes for their preparation App 20020094980 - Bunker, Amy Mae ; et al.	2002-07-18
Quinoxalinones as serine protease inhibitors App 20020086866 - Dudley, Danette Andrea ; et al.	2002-07-04
Certain benzothiazine dioxide endothelin antagonists and processes for their preparation App 20010036944 - Bunker, Amy Mae ; et al.	2001-11-01
Low molecular weight bicyclic thrombin inhibitors Grant 6,057,314 - Dimaio , et al. May 2, 2	2000-05-02
Phenylalanine derivatives as endothelin antagonists Grant 5,658,943 - Berryman , et al. August 19, 1	1997-08-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.